eplerenone tablet Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:16571-173 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient NameBasis of StrengthStrength EPLERENONE (UNII: 6995V82D0B) (EPLERENONE - UNII:6995V82D0B) EPLERENONE 25 mg Inactive Ing...
药品名称EPLERENONE 申请号078482产品号001 活性成分EPLERENONE市场状态处方药 剂型或给药途径TABLET;ORAL规格25MG 治疗等效代码AB参比药物否 批准日期2008/07/30申请机构APOTEX INC 化学类型审评分类 与本品相关的专利信息(来自橙皮书Orange Book) 专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载 ...
Absorption is not affected by food.The absolute bioavailability of eplerenone is 69% following administration of a 100 mg oral tablet. Both peak plasma levels (Cmax) and area under the curve (AUC) are dose proportional for doses of 25 mg to 100 mg and less than proportional at doses ...
Brand name: Inspra Dosage form: oral tablet (25 mg; 50 mg) Drug classes: Aldosterone receptor antagonists, Potassium-sparing diureticsMedically reviewed by Drugs.com on Mar 10, 2025. Written by Cerner Multum.Uses Side effects Warnings Before taking Dosage Interactions What...
Brand name:Selara Tablets 50mg Active ingredient:Eplerenone Dosage form:pale red tablet, diameter: 7.1mm, thickness: 4.0mmPrint on wrapping:セララ 50mg, Selara50mg, NSR50, 高血圧症慢性心不全の薬 Effects of this medicine This medicine inhibits the binding of aldosterone to receptors which is in...
Tablet 25 mg 50 mg Adult: Hypertension (HTN) Initial 50 mg orally once daily; may increase to 50 mg orally every 12 hours; may take up to four weeks for a full therapeutic response; hyperkalemia may occur with doses above 100 mg/day ...
(mg) of eplerenone (c 24 h 30 o 6 )in1 tablet assayweigh accurately the mass of not less than 20 eplerenone tablets, and powder. weigh accurately a portion of the powder, equivalent to about 50 mg of eplerenone (c 24 h 30 o 6 ), add a suitable amount of a mixture of aceto- ...
Aim: In a present work two drugs Torsemide and Eplerenone were estimated from their combined tablet dosage forms by applying chemometric assisted spectroph... A Madhuri,D Patel - 《Indian Journal of Pharmaceutical Education & Research》 被引量: 0发表: 2022年 A controlled trial of percutaneous ...
D. Searle & Co., Skokie, Ill., under the trademark “ALDACTONE”, in tablet dosage form at doses of 25 mg, 50 mg and 100 mg per tablet. Another group of aldosterone antagonists of particular interest are epoxy steroidal aldosterone antagonist compounds having a steroidal nucleus substituted ...
The hepatic first-pass metabolism of EPL is 12.6% and 27.1% under fasted and fed conditions, respectively, with a significant effect on drug bioavailability (69% for a 100 mg oral tablet). EPL is mainly excreted in urine with a t1/2 of 3 to 6 hours [14]. For efficient absorption ...